Nanoparticle-mediated drug delivery system for coronary artery disease

Tetsuya Matoba, Jun Ichiro Koga, Kaku Nakano, Kensuke Egashira

Research output: Contribution to journalReview articlepeer-review

Abstract

Coronary artery disease including acute myocardial infarction is a significant concern in cardiovascular medicine, because of their high acute mortality and morbidity causing lethal heart failure. Atherosclerotic plaque destabilization and rupture are central pathogenesis of acute myocardial infarction, whereas myocardial ischemia-reperfusion injury is another adverse phenomenon in the heart undergoing early reperfusion therapy for acute myocardial infarction. There are un-met needs for these pathological conditions to be overcome by the use of nanoparticle-mediated drug delivery system (DDS). We provide overview of the mechanistic background for the use of DDS and the efficacy of nano-medicine in preclinical disease models.

Original languageEnglish
Pages (from-to)299-308
Number of pages10
JournalDrug Delivery System
Volume30
Issue number4
DOIs
Publication statusPublished - Dec 25 2015

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science

Fingerprint Dive into the research topics of 'Nanoparticle-mediated drug delivery system for coronary artery disease'. Together they form a unique fingerprint.

Cite this